Compare CXDO & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CXDO | ANIK |
|---|---|---|
| Founded | 1995 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.1M | 200.9M |
| IPO Year | 1999 | 1996 |
| Metric | CXDO | ANIK |
|---|---|---|
| Price | $6.62 | $14.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $9.20 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 522.0K | 59.7K |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 166.67 | 80.16 |
| EPS | ★ 0.02 | N/A |
| Revenue | $68,167,000.00 | ★ $112,819,000.00 |
| Revenue This Year | $45.26 | $5.98 |
| Revenue Next Year | $13.31 | $7.42 |
| P/E Ratio | $334.50 | ★ N/A |
| Revenue Growth | ★ 12.05 | N/A |
| 52 Week Low | $5.26 | $7.90 |
| 52 Week High | $11.23 | $16.49 |
| Indicator | CXDO | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 34.41 | 46.28 |
| Support Level | $6.54 | $13.88 |
| Resistance Level | $7.02 | $15.53 |
| Average True Range (ATR) | 0.48 | 0.65 |
| MACD | -0.10 | -0.13 |
| Stochastic Oscillator | 29.63 | 17.80 |
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.